| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Shoulder Innovations, Inc.$18.96
+0.29 (+1.55%)
F 16Pipeline Score MedTech · Clinical
Market Cap
302.78 M
EPS
-2.15
P/E Ratio
-
Value Trade
1.02 M
SEC Financials
Q1 2026Dilution Risk
Revenue
16.71 M
R&D Expenses
3.75 M
Operating CF
-12.36 M
Total Assets
160.36 M
Total Liabilities
27.34 M
Equity
133.02 M
D/E Ratio
12,345
-5.5 %
Week
4.58 %
1 Month
9.45 %
3 Month
6.34 %
6 Month
-6.41 %
5 Year
-6.41 %
All Time
Cash Data
Cash Position
108.54 M
Monthly Burn
4.12 M
Runway
25.5 mo
Burn Trend
SEC Filing
May 13, 2026
Overview
Volume
10.21 K
52 Week Range
10.92 - 17.94
% held by Insiders
46.09 %
% held by Institutions
36.23 %
Enterprise Value
209.25 M
Total Shares
20.60 M
Short %
2.67 %
Float Shares
10.88 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
F16
Pipeline Score -
Pipeline ValueValuation Signal
0
Drugs Scored—
rNPV / MCap Top 12%
Micro Cap (rank 797 of 905)
Percentile RankShoulder Innovations, Inc. has significant pipeline risk (16/100).
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in SI
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
Shoulder Innovations, Inc. (SI) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
SI
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
SI
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
SI
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
SI Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
SI Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
SIShoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Shoulder Innovations, Inc. has announced its participation in the Goldman Sachs 47th Annual Global Healthcare Conference scheduled for June 9, 2026. The company is focused on transforming the shoulder surgical care market with advanced implant systems. Their ecosystem aims to enhance preoperative planning and procedural efficiency, addressing challenges in shoulder surgical care.
Read more →SIShoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year Outlook
Shoulder Innovations reported a strong financial performance for Q1 2026, with net revenue increasing by 65% to $16.7 million compared to the previous year. The company also raised its full year revenue guidance to between $65 million and $68 million, indicating robust growth prospects. However, the company faced increased operating losses and higher expenses in both selling and R&D.
Read more →SIShoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem
Shoulder Innovations has officially launched the InSet I-135RFX Humeral Stem after a successful limited market release and FDA clearance for additional fracture indications. This product expands their offerings in shoulder arthroplasty, allowing use in all primary, revision, and fracture procedures. The launch signifies a milestone for the company and showcases their dedication to improving surgical care.
Read more →SIShoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026
Shoulder Innovations, Inc. will announce its financial results for Q1 2026 on May 13, 2026. The company is focused on improving shoulder surgical care and will host a conference call to discuss the results. Interested parties can access the call through provided contact details.
Read more →SIShoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of Directors
Shoulder Innovations has appointed Drew Hykes to its Board of Directors, effective February 26, 2026. Hykes, a seasoned medical device executive, is expected to leverage his extensive experience to support the company's growth in the shoulder surgical care market. His appointment follows Geoff Pardo's resignation from the Board, who expressed confidence in the company's future.
Read more →SIShoulder Innovations to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Shoulder Innovations, Inc. will participate in the BTIG 13th Annual MedTech Conference on February 10-11, 2026. The company aims to transform shoulder surgical care with its advanced implant systems. Their ecosystem focuses on improving preoperative planning and procedural efficiency, addressing challenges in the shoulder surgical market.
Read more →Competitive Position
How SI ranks across every disease it competes inCompetitive Position is a premium feature
See how SI ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial